The World's First Successful Stem Cell Treatment of Autoimmune Diseases PDF Print E-mail
Wednesday, 23 November 2011 00:56
The efficacy on intravenous infusion of adipose-derived mesenchymal stem cells was studied by researchers from five different countries—South Korea, United States, Japan, China, and Germany. These findings were reported in the Journal of Translational Medicine, titled: "Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells."

Dr. Jeong Chan Ra and RNL research team were successful in treating patients with autoimmune diseases which were related to tissue damage and limited therapeutic options.

Autoimmune diseases arise when the body's immune system attacks itself. There are different kinds of autoimmune diseases which include systemic lupus, rheumatoid arthritis, multiple sclerosis, autoimmune hearing loss, spastic myelitis, Bechet's syndrome and so on. Symptoms of autoimmune diseases are long-term and result in permanent damage.

Dr. Ra's team previously demonstrated the safety on intravenous infusion of adipose-derived stem cells in humans. In addition to the safety, the team identified the efficacy on these diseases such as autoimmune hearing loss, multiple sclerosis, polymyositis, atopic dermatitis, and rheumatoid arthritis, in this study. Patients who received stem cell infusion multiple times showed no adverse effects as well as side effects.

In the case of autoimmune hearing loss, the patient was administered with her own stem cells. Her hearing returned to normal (scaled out to 15dB) while she didn't respond to steroids.

A multiple sclerosis patient suffered from severe side effects from high dose steroids and had difficulty walking. The patient's condition improved tremendously from administration of stem cells intravenously as well as intra-thecally. In addition, the patient was able to move her legs using her own muscular strength.

Other autoimmune diseases including multiple sclerosis, atopic dermatitis, and rheumatoid arthritis were not able to be treated with existing medication. However, these illnesses became manageable with stem cell treatment.

Researchers are continuing to develop sophisticated stem cell technology using 5g of fat as a standard, which can be expanded to 1 billion stem cells. Moreover, this technology became more efficient and convenient for patients because repetitive stem cell injections are possible from one time fat extraction. Their studies also showed the stem cell's homing effect, by which patients need less surgeries and transplants.

Dr. Jeong Chan Ra, president of RNL Stem Cell Technology Institute expressed, "The fact that we showed the way patients can be treated from their own stem cells is very rewarding to me." Dr. Ra added, "We are working towards becoming our country's medical hub for treating autoimmune diseases."

Source: PRNewswire
 
More articles :

» The SCOT Study

SCOT is a clinical research study designed for people with severe forms of . SCOT stands for Scleroderma: Cyclophosphamide Or Transplantation. The SCOT study will compare the potential benefits of stem cell transplant and high-dose monthly...

» Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Tracy Frech, Kirsten Novak, Monica P. Revelo, Maureen Murtaugh, Boaz Markewitz, Nathan Hatton, Mary Beth Scholand, Edward Frech, David Markewitz, and Allen D. SawitzkeReceived 31 May 2011; Accepted 14 July 2011Systemic sclerosis (SSc; scleroderma)...

» Optical Coherence Tomography: The first Quantitative Imaging Biomarker for Scleroderma

Using the , manufactured in the UK by Michelson Diagnostics Ltd, scientists at the Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds have developed the first quantitative imaging biomarker for skin involvement in . Scleroderma...

» Comprehensive Report on the Global State of Autoimmune Diseases Released

A groundbreaking new report from the (AARDA), examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit:  The Global State...

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» Women and Autoimmunity

50:1, 9:1, 2:1 these are just some ratios of autoimmune disease disparities between women and men. The Society for Women’s Health Research (SWHR) hosted the Capitol Hill briefing, The War Within: Women and Autoimmunity, on Tuesday, October 11 to...

Comments  

 
+1 #1 valarmie@yahoo.com 2011-12-03 22:36
FYI
Quote | Report to administrator
 

Add comment

Do feel free to leave your comments, as they would add value and knowledge to the community. However, please refrain from making any disparaging, uninformed, or unrelated comments. Thanks :)

Security code
Refresh